Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.538
-0.029 (-5.16%)
Nov 5, 2024, 11:09 AM EST - Market open
MTNB Employees
Matinas BioPharma Holdings had 32 employees as of December 31, 2023. The number of employees decreased by 2 or -5.88% compared to the previous year.
Employees
32
Change (1Y)
-2
Growth (1Y)
-5.88%
Revenue / Employee
n/a
Profits / Employee
-$716,000
Market Cap
2.70M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Molecular Templates | 62 |
| iSpecimen | 53 |
| Scinai Immunotherapeutics | 31 |
| ReShape Lifesciences | 29 |
| Sonnet BioTherapeutics Holdings | 12 |
| Phio Pharmaceuticals | 9 |
| Tharimmune | 3 |
| Protagenic Therapeutics | 3 |
MTNB News
- 5 days ago - Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - GlobeNewsWire
- 2 months ago - Matinas BioPharma Holdings, Inc. (MTNB) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 3 months ago - Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024 - GlobeNewsWire
- 4 months ago - Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program - GlobeNewsWire
- 5 months ago - Matinas BioPharma's Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. - GlobeNewsWire
- 6 months ago - New In Vitro Data Showing Matinas BioPharma's LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 - GlobeNewsWire
- 6 months ago - Matinas BioPharma Holdings, Inc. (MTNB) Q1 2024 Earnings Call Transcript - Seeking Alpha